| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.5M | +21.9% |
| Cost of Revenue | $11.0M | +19.5% |
| Gross Profit | $7.6M | +25.6% |
| R&D Expense | $1.3M | -23.5% |
| Operating Income | -$4.2M | +44.7% |
| Pre-tax Income | -$4.3M | +26.7% |
| Income Tax | $0 | — |
| Net Income | -$4.3M | +26.7% |
| EPS (Basic) | -$2.93 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -7.5% |
| Accounts Receivable | $799K | -38.6% |
| Inventory | $724K | +88.5% |
| Current Assets | $3.5M | -6.3% |
| Total Assets | $17.0M | -6.1% |
| Current Liabilities | $4.3M | +36.0% |
| Long-term Debt | $383K | +8.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $439K | +112.3% |
| Capital Expenditures | $223K | +77.0% |
| Investing Cash Flow | -$223K | -77.0% |
| Financing Cash Flow | -$329K | -118.9% |
| Free Cash Flow | $216K | +105.9% |
| +35.0% |
| EPS (Diluted) | -$2.93 | +35.0% |
| Total Liabilities |
| $4.9M |
| +33.5% |
| Stockholders' Equity | $12.1M | -16.2% |